NeoGenomics Ownership | Who Owns NeoGenomics?


OverviewForecastRevenueFinancialsChartTranscripts

NeoGenomics Ownership Summary


NeoGenomics is owned by 502.02% institutional investors, 1.29% insiders. Blackrock funding, inc. /de is the largest institutional shareholder, holding 76.07% of NEO shares. iShares Core S&P Small-Cap ETF is the top mutual fund, with 5.93% of its assets in NeoGenomics shares.

NEO Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockNeoGenomics502.02%1.29%-403.31%
SectorHealthcare Stocks 42.64%10.86%46.50%
IndustryDiagnostics & Research Stocks46.31%10.49%43.20%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock funding, inc. /de19.46M76.07%$228.87M
Vanguard group13.83M54.05%$162.62M
First light asset management9.93M38.79%$76.64M
Greenhouse funds lllp8.22M32.12%$63.46M
State street4.98M19.46%$58.54B
Deerfield management company, l.p. (series c)4.45M17.38%$34.33M
Blackrock19.67M15.56%$272.82M
Schroder investment management group3.48M13.61%$27.06B
Geode capital management3.18M12.42%$37.36M
Dimensional fund advisors lp2.45M9.57%$28.80M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
First light asset management9.93M7.22%$76.64M
Highmark wealth management567.33K2.72%$6.67M
Greenhouse funds lllp8.22M2.32%$63.46M
Perkins capital management141.85K1.32%$1.67M
Pfm health sciences, lp2.21M1.31%$17.05M
Bullseye asset management236.86K0.96%$1.83M
Samjo management289.80K0.85%$2.24M
American capital management2.35M0.72%$18.11M
Bryce point capital64.08K0.60%$494.73K
Deerfield management company, l.p. (series c)4.45M0.52%$34.33M

Top Buyers

HolderShares% AssetsChange
Millennium management6.72M0.03%5.29M
First light asset management9.93M7.22%3.08M
Deerfield management company, l.p. (series c)4.45M0.52%2.30M
Braidwell lp1.77M0.41%1.77M
Loomis sayles & co l p1.63M0.02%1.63M

Top Sellers

HolderShares% AssetsChange
American century companies22.11K0.00%-3.50M
Macquarie group---2.54M
T. rowe price investment management1.31M0.01%-1.96M
Jennison associates---1.66M
Dimensional fund advisors lp2.45M0.01%-1.38M

New Positions

HolderShares% AssetsChangeValue
Braidwell lp1.77M0.41%1.77M$13.67M
Loomis sayles & co l p1.63M0.02%1.63M$19.18M
Soleus capital management427.50K0.19%427.50K$5.03M
Norges bank380.66K0.00%380.66K$6.27M
Silverback asset management201.31K0.15%201.31K$1.55M

Sold Out

HolderChange
Dinuzzo private wealth-1.00
Bay harbor wealth management-1.00
Capital performance advisors llp-2.00
Elequin securities-2.00
Claris advisors, llc / mo /-10.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 2025245-10.58%128,465,4675.96%5025.59%117-22.52%8325.76%
Jun 30, 20252785.70%127,009,8850.72%991.01%15435.09%67-25.56%
Mar 31, 20258-96.91%13,898,618-88.67%100.12%5-94.95%2-97.94%
Dec 31, 2024240-13.04%116,927,608-5.30%920.97%91-18.02%90-2.17%
Sep 30, 20242745.38%122,547,008-2.58%960.97%1118.82%91-1.09%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
iShares Core S&P Small-Cap ETF7.66M5.93%-
Vanguard Total Stock Mkt Idx Inv4.03M3.12%-89.48K
Vanguard US Total Market Shares ETF3.99M3.11%4.14K
Macquarie Small Cap Core I3.61M2.79%-271.16K
Delaware Small Cap Core I3.12M2.44%478.93K
Vanguard Small Cap Index3.12M2.42%-23.01K
iShares Russell 2000 ETF3.09M2.39%-
American Century Small Cap Growth Inv2.75M2.14%150.02K
American Century U.S. Small Cap Growth2.75M2.14%150.02K
Janus Henderson US SMID Cap Growth MA2.03M1.58%2.03M

Recent Insider Transactions


DateNameRoleActivityValue
Jan 20, 2026Stone Warren Pres & Chief Operating OfficerSell$276.68K
Nov 25, 2025Olivo Alicia C EVP, GC & Business DevelopmentSell$250.99K
Aug 06, 2025Sherman Jeffrey Scott Chief Financial OfficerBuy$112.32K
Aug 06, 2025Zook Anthony P. Chief Executive OfficerBuy$99.95K
May 27, 2025Kelly Michael Aaron-Buy$38.00K

Insider Transactions Trends


DateBuySell
2026 Q1-1
2025 Q4-1
2025 Q32-
2025 Q28-
2025 Q1--

NEO Ownership FAQ


Who Owns NeoGenomics?

NeoGenomics shareholders are primarily institutional investors at 502.02%, followed by 1.29% insiders and -403.31% retail investors. The average institutional ownership in NeoGenomics's industry, Diagnostics & Research Stocks, is 46.31%, which NeoGenomics exceeds.

Who owns the most shares of NeoGenomics?

NeoGenomics’s largest shareholders are Blackrock funding, inc. /de (19.46M shares, 76.07%), Vanguard group (13.83M shares, 54.05%), and First light asset management (9.93M shares, 38.79%). Together, they hold 168.92% of NeoGenomics’s total shares outstanding.

Does Blackrock own NeoGenomics?

Yes, BlackRock owns 15.56% of NeoGenomics, totaling 19.67M shares as of Jun 2024. This represents 0.01% of BlackRock's total assets, with a market value of 272.82M$. In the last quarter, BlackRock decreased its holdings by -181K shares, a -0.91% change.

Who is NeoGenomics’s biggest shareholder by percentage of total assets invested?

First light asset management is NeoGenomics’s biggest shareholder by percentage of total assets invested, with 7.22% of its assets in 9.93M NeoGenomics shares, valued at 76.64M$.

Who is the top mutual fund holder of NeoGenomics shares?

iShares Core S&P Small-Cap ETF is the top mutual fund holder of NeoGenomics shares, with 5.93% of its total shares outstanding invested in 7.66M NeoGenomics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools